New combo shows promise for Drug-Resistant lung cancer
NCT ID NCT04245085
First seen May 16, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study tested a combination of two immunotherapy drugs (atezolizumab and bevacizumab) plus chemotherapy in 95 people with advanced EGFR-mutant lung cancer whose tumors had stopped responding to standard targeted therapy. The goal was to see if this new mix could control the cancer for at least 12 months. Participants received one of two chemotherapy backbones alongside the immunotherapy. The trial aimed to find better options for patients with limited choices after targeted drugs fail.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EGFRMUTANT STAGE IIIB/C OR IV NON-SQUAMOUS NSCLC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asklepios Fachkliniken München-Gauting
München, Germany
-
Complejo Hospitalario de Jaén
Jaén, Spain
-
Hospital De La Santa Creu I Sant Pau
Barcelona, Spain
-
Hospital General de Valencia
Valencia, Spain
-
Hospital Puerta de Hierro
Madrid, Spain
-
Hospital Teresa Herrera
A Coruña, Spain
-
Hospital Universitario Fundacion Jimenez Díaz
Madrid, Spain
-
Hospital Universitario Insular Gran Canaria
Las Palmas de Gran Canaria, Spain
-
Hôpitaux Universitaires de Genève
Geneva, Switzerland
-
ICO - Hospital Universitari Germans Trias i Pujol
Badalona, Spain
-
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
-
LungenClinic Grosshansdorf
Großhansdorf, Germany
-
National Cancer Center
Goyang, South Korea
-
National University Hospital
Singapore, Singapore
-
OSI Bilbao Basurto
Bilbao, Spain
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
-
UniversitätsSpital Zürich
Zurich, Switzerland
-
Vall d'Hebron University Hospital
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.